2021 — Mird237

Based on the available information, is an adult film title released in by the Japanese studio

• MIRD Pamphlet No. 24 (2021): "A Resource for the Use of Radiopharmaceuticals in Molecular Imaging and Therapy"

MIRD Pamphlet 24 (2021): A Resource for the Use of Radiopharmaceuticals in Molecular Imaging and Therapy
Clarification: The reference "MIRD237 2021" likely refers to MIRD Pamphlet No. 24, published in 2021, as "MIRD237" does not correspond to any known publication in the Medical Internal Radiation Dose (MIRD) series. This write-up focuses on MIRD Pamphlet 24, a significant 2021 publication by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). mird237 2021

Reviews from specialized community forums and database sites like generally highlight: Performance: Based on the available information, is an adult

specifically from 2021, you may find relevant peer-reviewed research through the Journal of Nuclear Medicine (JNM) MIRD Committee's resources Could you clarify if you were looking for a scientific document or if this code relates to a specific media file you encountered? MIRD Pamphlet No

Solubility Profile (2021 Standard)

• Soluble in: DMSO (Dimethyl sulfoxide) > 25 mg/mL; Ethanol (anhydrous) ~ 10 mg/mL.
• Insoluble in: Water (aqueous buffers at pH 7.0).

Comparison: MIRD237 Pre-2021 vs. 2021

To understand why the year "2021" is critical, compare the archived data:

References & Further Reading

1. Bolch WE, et al. “MIRD pamphlet No. 237: Voxel-based computational phantoms for internal dosimetry.” J Nucl Med. 2021;62(Suppl 3):12S-20S.
2. Stabin MG, et al. “OLINDA/EXM version 2.0 – a MIRD237 2021 compliant platform.” Med Phys. 2022;49(4):2284-2296.
3. ICRP Publication 148. “Dose coefficients for radiopharmaceuticals.” Ann ICRP. 2021;50(2):1-192.
4. SNMMI Dosimetry Toolkit – https://www.snmmi.org/dosimetry (Accessed 2025)